pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-758 |
Genomic Coordinates | chr14: 101026020 - 101026107 |
Synonyms | MIRN758, hsa-mir-758, MIR758 |
Description | Homo sapiens miR-758 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-758-5p | |||||||||||||||||||||||||||||||||||||||||||||
Sequence | 15| GAUGGUUGACCAGAGAGCACAC |36 | |||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||||||||
Experiments | SOLiD | |||||||||||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PTP4A1 | ||||||||||||||||||||
Synonyms | HH72, PRL-1, PRL1, PTP(CAAX1), PTPCAAX1 | ||||||||||||||||||||
Description | protein tyrosine phosphatase type IVA, member 1 | ||||||||||||||||||||
Transcript | NM_003463 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PTP4A1 | |||||||||||||||||||||
3'UTR of PTP4A1 (miRNA target sites are highlighted) |
>PTP4A1|NM_003463|3'UTR 1 AATTGGGGTGCCTAATGCTACTGGAAGTGGAACTTGAGATAGGGCCTAATTTGTTATACATATTAGCCAACATGTTGGCT 81 TAGTAAGTCTAATGAAGCTTCCATAGGAGTATTGAAAGGCAGTTTTACCAGGCCTCAAGCTAGACAGATTTGGCAACCTC 161 TGTATTTGGGTTACAGTCAACCTATTTGGATACTTGGCAAAAGATTCTTGCTGTCAGCATATAAAATGTGCTTGTCATTT 241 GTATCAATTGACCTTTCCCCAAATCATGCAGTATTGAGTTATGACTTGTTAAATCTATTCCCATGCCAGAATCTTATCAA 321 TACATAAGAAATTTAGGAAGATTAGGTGCCAAAATACCCAGCACAATACTTGTATATTTTTAGTACCATACAGAAGTAAA 401 ATCCCAGGAACTATGAACACTAGACCTTATGTGGTTTATTCCTTCAATCATTTCAAACATTGAAAGTAGGGCCTACATGG 481 TTATTTGCCTGCTCACTTTATGTTTACATCTCCCACATTCATACCAATATACGTCAGGTTTGCTTAACCATTGATTTTTT 561 TTTTTTTTTACCAAGTCTTACAGTGATTATTTTACGTGTTTCCATGTATCTCACTTTGTGCTGTATTAAAAAAACCTCCA 641 TTTTGAAAATCTACGTTGTACAGAAGCACATGTCTTTAATGTCTTCAGACAAAAAAGCCTTACATTAATTTAATGTTTGC 721 ACTCTGAGGTGCAACTTAACAGGGAGGGCCTGAGAAAAGAATGGGAGGGGGCTATTAATTATTTTTAGCAAAATGTTGCC 801 TTTGTCTTGTGCAAACATGTAGAATATGCTCTTTAATTTAGTAAAATATTTTTTTAAAAGGTAGAGATGCTTTGTTATTG 881 TAATCATAAACTTCCTGAAATTCTTGTAATTTTTTTCCCATACTTATCAGAAGTGTGTTTACCAACTTATTTTTGTTTGA 961 AAGTGTGATTTTTTTTTTCCTTCCCAACCTCTCTTGCAAAAAAAGAAATGGGTTTCTGCTAATGAATTGAGCAGACATCT 1041 AATATTTTATATGCCTTTTGAGCTGTGTAACTTAATATTTGGATACTTGACAATTTGTTTTATTATGTAATTGATAAAAT 1121 GGTGATGTGTATTAATGTTAGTTCAACCATATATTTATACTGTCTGGGGATGTGTGGTTATAGTTCTGTGGGAGAAATAA 1201 TTTTGTCAGTGTTCACCAGCTTGTAAAAACTTAGTGCGAGAGCTGAAACATCTAAATAAATAATGACATGCATTTATCAT 1281 CATTGAGATTGGTTTGCTTAAAATTAACTTATTTTGTAGAAGACAAAATGAATTGCACTTCACTTAATGTGTGTCCTCAT 1361 CTTTTTACAAATAAATGAAGGATTATAAATGATGTCAGCATTTTAGTAAACTTTTAGACAAAATTTGTTAGGGTCATTCA 1441 TGAAAACTTTAATACTAAAAGCACTTTCCATTATATACTTTTTAAAGGTCTAGATAATTTTGAACCAATTTATTATTGTG 1521 TACTGAGGAGAAATAATGTATAGTAGAGGACAGCCTTGGTTTGTAAAGCTCAGTTCCACTAGTTCATGGTTTTGTGCAAC 1601 TTCTGAGCCTCAGTTTTCTCCTTTGCAAATTAATAATTACATACCTTTATAGATTTTGAAATTAATTTAAATATTAGTAT 1681 TTGGTACATGAAGGCTTAATGTTAAGTTTCCTTTAATGATCCACAATAATCCCTTTGATCACGTTAATCTAAATCTAGAT 1761 GTCTTTGTCTAATTTTTTTTGAATAGCAGTTATAAATGTAAAGGACTCAAAGTTTAAGTAAAAAGTGATACTCCACCTTG 1841 TGTTTCAAAGAATTTAGTTCCACCTCTTCATACCAGTTTAACACTTAATATATTTCATTGGATTTTAGACAGGGCAAAAG 1921 GAAGAACAGGGGCCTCTGGAGGCCCTTGGTTATTTAAATCTTGGATTATTTGTGATAGTAATCACAAATTTTTGGCTAAT 2001 TTTTAACCTGAGGTTTTGTTTTTTTTTTAAAGGAAATGCAGCCTAGTCTTGAGAACATAATTTTATATAATCAATTACTA 2081 AATGTTAAACTATTACCACACAGCCCATAAAACAGCATTTGCGTTTATTGAGAGAGAGGATGTGCCATCATGATTAATGA 2161 AAACTATCTTTTGAGTTTGAAAAGAAATTAATTTGCAGTGTTTGGATTGTATATATGGTGCTAAAAATAAATTAATTTAC 2241 TTTATAAACCTTATCTGTACATTATACGATGTGATGAAATTTGCTTTTTATCCAAATATTTTGTATCTTGTAAATATGGC 2321 TAATTATAGGAATGCCTATAATACATCTTAGATTCCTTATATCTAATAAGAGTTCAAAGAGTTATGAGTTGAAGTCTTGA 2401 ATGCAGGAAACTATCTGATAGTGTTCTAAAATTTGGTTACTTGGGTTTGGATACCCTTAGTGGGATGATGTAAATAGAGG 2481 CTAGCTACCTAGGCTTGTCTATAGCAACCATAATGTTGATGTAAGTAATGCGGTTACTGAATCATAAGAAAATGCCATCT 2561 CTTTTTAGTTGAAGGAAAACTCTGGAAGTAGGTGCCATTGGTCATTCTGCAGTGCACTGCAACCATTGTTTCCCCTAGTG 2641 CCCTCTTTTCCCTAGGGCATTGCTCTCCTATTCCCACGCCTTAACACAGCTCTATACCTAGAAGCAGCCAGCCCAGGCAT 2721 GCAGTCACATTTAATCACATCCCCCTTCTAGAGTGCTTCAAAATGATGTAGTCCCTCAACTTGGCTAAAGAATCTCAATC 2801 TCTTGAAATTTATTTTTTTAATGTCATATTCATCTGGTAAATATCTACTGTTTGCCAGGCATTTAAGAATATGGCAAAGA 2881 ACATAAAAGATGGTGTCACCAGATTTTGGTCACCAATGAGTACCCGACCCGTTGCCATGATTAAGAGAGAATGCTTTCTA 2961 TTGGAGTTTCAGGAAATATAATTTGAGAATACTTTAAAGGGAAGTGGAAGTATAAGTGAATGATATTTTTCTTTTACATG 3041 TAAACAATGAAGTTATTTCAAAGTTAAGTTTTAAACAAAATACATGAAGTAGTGTCTGCCATACATGTTAATATTCTACA 3121 TTCTTGCTTCCTTAAATTAATATGTTTGTGTGTATATATGTGCCTCACACCTGAATTGAAAATTAAAGACTGGTTTAAAA 3201 GTGGTTTAAAAGTGACATTTAATGTTTCTCCATTACGTTTGGGGTAACCAGCCTAAGTGGAATCTTGGAAGGAAAGTAAG 3281 GGAAAAACTTGTATTTGCCTTCAATGAATTAAACCAGTGATATGTGTTAACGTATGAATGAAAGGATTGATGGTGATTTT 3361 ATAATTATATATATTGCCGCAGTAACCAGTTAATAAATTGATAGCTACCATTTAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000370651.3 | 3UTR | AUUAAUGUUAGUUCAACCAUAUAUUUAUACUGUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
62 hsa-miR-758-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT085323 | MORC3 | MORC family CW-type zinc finger 3 | 2 | 2 | ||||||||
MIRT089441 | STAMBP | STAM binding protein | 2 | 2 | ||||||||
MIRT089456 | TET3 | tet methylcytosine dioxygenase 3 | 2 | 2 | ||||||||
MIRT111856 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT184933 | ZNF268 | zinc finger protein 268 | 2 | 2 | ||||||||
MIRT215288 | CREBRF | CREB3 regulatory factor | 2 | 2 | ||||||||
MIRT237300 | LPP | LIM domain containing preferred translocation partner in lipoma | 2 | 2 | ||||||||
MIRT238446 | MYO10 | myosin X | 2 | 4 | ||||||||
MIRT273827 | RPL41 | ribosomal protein L41 | 2 | 2 | ||||||||
MIRT282703 | HOOK1 | hook microtubule tethering protein 1 | 2 | 2 | ||||||||
MIRT347970 | ZNF850 | zinc finger protein 850 | 2 | 2 | ||||||||
MIRT371076 | KLF3 | Kruppel like factor 3 | 2 | 2 | ||||||||
MIRT464339 | USP6NL | USP6 N-terminal like | 2 | 2 | ||||||||
MIRT470034 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 2 | 2 | ||||||||
MIRT477506 | ELL2 | elongation factor for RNA polymerase II 2 | 2 | 2 | ||||||||
MIRT482886 | CACNA2D3 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | 2 | 2 | ||||||||
MIRT492606 | POLR3E | RNA polymerase III subunit E | 2 | 2 | ||||||||
MIRT502294 | GNG12 | G protein subunit gamma 12 | 2 | 6 | ||||||||
MIRT507600 | DCTN4 | dynactin subunit 4 | 2 | 4 | ||||||||
MIRT510728 | SON | SON DNA binding protein | 2 | 6 | ||||||||
MIRT514065 | KCNJ6 | potassium voltage-gated channel subfamily J member 6 | 2 | 8 | ||||||||
MIRT519718 | ZNF512B | zinc finger protein 512B | 2 | 4 | ||||||||
MIRT520890 | STRN | striatin | 2 | 2 | ||||||||
MIRT521760 | PPIL1 | peptidylprolyl isomerase like 1 | 2 | 6 | ||||||||
MIRT526874 | ERCC8 | ERCC excision repair 8, CSA ubiquitin ligase complex subunit | 2 | 2 | ||||||||
MIRT530232 | WSB2 | WD repeat and SOCS box containing 2 | 2 | 2 | ||||||||
MIRT532003 | ACTR2 | ARP2 actin related protein 2 homolog | 2 | 2 | ||||||||
MIRT533371 | UBE2D4 | ubiquitin conjugating enzyme E2 D4 (putative) | 2 | 4 | ||||||||
MIRT547106 | PIGW | phosphatidylinositol glycan anchor biosynthesis class W | 2 | 2 | ||||||||
MIRT548189 | FOXA1 | forkhead box A1 | 2 | 2 | ||||||||
MIRT552935 | VKORC1L1 | vitamin K epoxide reductase complex subunit 1 like 1 | 2 | 2 | ||||||||
MIRT560085 | ZNF195 | zinc finger protein 195 | 2 | 2 | ||||||||
MIRT561726 | PPP2CA | protein phosphatase 2 catalytic subunit alpha | 2 | 2 | ||||||||
MIRT562713 | ZNF415 | zinc finger protein 415 | 2 | 2 | ||||||||
MIRT562761 | ZNF846 | zinc finger protein 846 | 2 | 2 | ||||||||
MIRT564159 | ZNF117 | zinc finger protein 117 | 2 | 2 | ||||||||
MIRT565673 | SETD5 | SET domain containing 5 | 2 | 2 | ||||||||
MIRT565718 | SESN3 | sestrin 3 | 2 | 2 | ||||||||
MIRT566026 | RFX1 | regulatory factor X1 | 2 | 2 | ||||||||
MIRT569048 | ZNF655 | zinc finger protein 655 | 2 | 2 | ||||||||
MIRT570367 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 2 | 2 | ||||||||
MIRT570410 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 2 | 2 | ||||||||
MIRT570443 | TMEM189 | transmembrane protein 189 | 2 | 2 | ||||||||
MIRT571738 | RNF11 | ring finger protein 11 | 2 | 2 | ||||||||
MIRT575042 | Tpgs2 | tubulin polyglutamylase complex subunit 2 | 2 | 4 | ||||||||
MIRT614330 | ZDHHC22 | zinc finger DHHC-type containing 22 | 2 | 2 | ||||||||
MIRT617629 | RAB3IP | RAB3A interacting protein | 2 | 2 | ||||||||
MIRT621667 | UBE4B | ubiquitination factor E4B | 2 | 2 | ||||||||
MIRT639906 | SRGAP2 | SLIT-ROBO Rho GTPase activating protein 2 | 2 | 2 | ||||||||
MIRT651436 | XRCC5 | X-ray repair cross complementing 5 | 2 | 2 | ||||||||
MIRT683853 | ZNF208 | zinc finger protein 208 | 2 | 2 | ||||||||
MIRT684841 | TPGS2 | tubulin polyglutamylase complex subunit 2 | 2 | 5 | ||||||||
MIRT689347 | ZNF83 | zinc finger protein 83 | 2 | 2 | ||||||||
MIRT692492 | SPIN4 | spindlin family member 4 | 2 | 2 | ||||||||
MIRT695711 | OLA1 | Obg like ATPase 1 | 2 | 2 | ||||||||
MIRT698219 | TMEM248 | transmembrane protein 248 | 2 | 2 | ||||||||
MIRT711560 | FAM20B | FAM20B, glycosaminoglycan xylosylkinase | 2 | 2 | ||||||||
MIRT712867 | TMEM67 | transmembrane protein 67 | 2 | 2 | ||||||||
MIRT722956 | TSPAN1 | tetraspanin 1 | 2 | 2 | ||||||||
MIRT723622 | SOBP | sine oculis binding protein homolog | 2 | 2 | ||||||||
MIRT724176 | ABCF2 | ATP binding cassette subfamily F member 2 | 2 | 2 | ||||||||
MIRT755363 | LMBR1 | limb development membrane protein 1 | 3 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|